Insulin-like growth factor-1 and post-ischemic brain injury

Progress in Neurobiology

Volumn 70, Issue 6, 2003, Pages 443-462

  Guan, J ^a   Bennet, L ^a   Gluckman, P D ^a   Gunn, A J ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

APOPTOSIS; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL ACTIVATION; CELL TYPE; CELLULAR DISTRIBUTION; DOSE RESPONSE; EVALUATION; GRAY MATTER; HYPOTHERMIA; NEUROPROTECTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SHEEP; SOMATOSENSORY CORTEX; WHITE MATTER;

EID: 0141956456     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2003.08.002     Document Type: Review

References (194)

1. Aizenman Y., De Vellis J. Brain neurons develop in a serum and glial free environment: effects of transferrin, insulin, insulin-like growth factor-I and thyroid hormone on neuronal survival, growth and differentiation. Brain Res. 406:1987;32-42.
2. Andine P., Jacobson I., Hagberg H. Calcium uptake evoked by electrical stimulation is enhanced postischemically and precedes delayed neuronal death in CA1 of rat hippocampus: involvement of N-methyl-D-aspartate receptors. J. Cereb. Blood Flow Metab. 8:1988;799-807.
3. Araujo D.M., Lapchak P.A., Collier B., Chabot J.-G., Quirion R. Insulin-like growth factor-1 (somatomedin-C) receptors in the rat brain: distribution and interaction with the hippocampal cholinergic system. Brain Res. 484:1989;130-138.
4. Auer R.N. Insulin, blood glucose levels, and ischemic brain damage. Neurology. 51:1998;S39-S43.
5. Baker N.L., Carlo R.V., Bernard O., D'Ercole A.J., Werther G.A. Interactions between bcl-2 and the IGF system control apoptosis in the developing mouse brain. Brain Res. Dev. Brain Res. 118:1999;109-118.
6. Ballotti R., Nielsen F.C., Pringle N., Kowalski A., Richardson W.D., Van Obberghen E., Gammeltoft S. Insulin-like growth factor I in cultured rat astrocytes: expression of the gene, and receptor tyrosine kinase. EMBO J. 6:1987;3633-3639.
7. Beck K.D., Powell-Braxton L., Widmer H.R., Valverde J., Hefti F. IGF1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron. 14:1995;717-730.
8. Beilharz E.J., Bassett N.S., Sirimanne E.S., Williams C.E., Gluckman P.D. Insulin-like growth factor II is induced during wound repair following hypoxic-ischemic injury in the developing rat brain. Brain Res. Mol. Brain Res. 29:1995a;81-91.
9. Beilharz E.J., Williams C.E., Dragunow M., Sirimanne E.S., Gluckman P.D. Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss. Mol. Brain Res. 29:1995b;1-14.
10. Beilharz E.J., Russo V.C., Butler G., Baker N.L., Connor B., Sirimanne E.S., Dragunow M., Werther G.A., Gluckman P.D., Williams C.E., Scheepens A. Co-ordinated and cellular specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic-ischemic injury. Mol. Brain Res. 59:1998;119-134.
11. Benveniste H., Drejer J., Schousboe A., Diemer N.H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374.
12. Bergstedt K., Wieloch T. Changes in insulin-like growth factor 1 receptor density after transient cerebral ischemia in the rat. Lack of protection against ischemic brain damage following injection of insulin-like growth factor 1. J. Cereb. Blood Flow Metab. 13:1993;895-898.
13. Betz A.L., Keep R.F., Beer M.E., Ren X.D. Blood-brain barrier permeability and brain concentration of sodium, potassium, and chloride during focal ischemia. J. Cereb. Blood Flow Metab. 14:1994;29-37.
14. Bohannon N.J., Corp E.S., Wilcox B.J., Figlewicz D.P., Dorsa D.M., Baskin D.G. Localization of binding sites for insulin-like growth factor-1 (IGF-1) in the rat brain by quantitative autoradiography. Brain Res. 444:1988;205-213.
15. Boris-Möller F., Smith M.-L., Siesjö B.K. Effects of hypothermia on ischemic brain damage: a comparison between preischemic and postischemic cooling. Neurosci. Res. Commun. 5(2):1989;87-94.
16. Bourner M.J., Busby W.H. Jr., Siegel N.R., Krivi G.G., McCusker R.H., Clemmons D.R. Cloning and sequence determination of bovine insulin-like growth factor binding protein-2 (IGFBP-2): comparison of its structural and functional properties with IGFBP-1. J. Cell. Biochem. 48:1992;215-226.
17. Brass B.J., Nonner D., Barrett J.N. Differential effects of insulin on choline acetyltransferase and glutamic acid decarboxylase activities in neuron-rich striatal cultures. J. Neurochem. 59:1992;415-424.
18. Brown A., Brierley J. The nature, distribution and earliest stages of anoxic-ischemic nerve cell damage in the rat brain as defined by the optical microscope. Br. J. Exp. Pathol. 49:1968;87-106.
19. Calissano P., Ciotti M.T., Battistini L., Zona C., Angelini A., Merlo D., Mercanti D. Recombinant human insulin-like growth factor-I exerts a trophic action and confers glutamate sensitivity on glutamate-resistant cerebellar granule cells. Proc. Natl. Acad. Sci. U.S.A. 90:1993;8752-8756.
20. Cao Y., Gunn A.J., Bennet L., Wu D., George S., Gluckman P.D., Shao X.M., Guan J. Insulin-like growth factor (IGF)-1 suppresses oligodendrocyte caspase-3 activation and increases glial proliferation after ischemia in near-term fetal sheep. J. Cereb. Blood Flow Metab. 23:2003;739-747.
21. Carder P.L., Hume R., Fryer A.A., Strante R.C., Lauder J., Bell J.E. Glutathione S-transferase in human brain. Neuropathol. Appl. Neurobiol. 16:1990;293-303.
22. Carlsson Skwirut C., Lake M., Hartmanis M., Hall K., Sara V.R. A comparison of the biological activity of the recombinant intact and truncated insulin-like growth factor 1 (IGF-1). Biochim. Biophys. Acta. 1011:1989;192-197.
23. Caroni P., Grandes P. Nerve sprouting in innervated adult muscle induced by exposure to elevated levels of insulin-like growth factors. J. Cell Biol. 110:1990;1307-1317.
24. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., Peterson P.K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149:1992;2736-2741.
25. Chen J.C., Shao Z.M., Sheikh M.S., Hussain A., LeRoith D., Roberts C.T. Jr., Fontana J.A. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. J. Cell. Physiol. 158:1994;69-78.
26. Cheng H.L., Steinway M., Delaney C.L., Franke T.F., Feldman E.L. IGF-I promotes Schwann cell motility and survival via activation of Akt. Mol. Cell. Endocrinol. 170:2000;211-215.
27. Cherian L., Goodman J.C., Robertson C.S. Effect of glucose administration on contusion volume after moderate cortical impact injury in rats. J. Neurotrauma. 15:1998;1059-1066.
28. Chernausek S.D. Insulin-like growth factor-I (IGF-I) production by astroglial cells: regulation and importance for epidermal growth factor-induced cell replication. J. Neurosci. Res. 34:1993;189-197.
29. Clark R.G., Mortensen D., Reifsynder D., Mohler M., Etcheverry T., Mukku V. Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3): effects on the glycemic and growth promoting activities of rhIGF-1 in the rat. Growth Regul. 3:1993;50-52.
30. Clawson T.F., Vannucci S.J., Wang G.M., Seaman L.B., Yang X.L., Lee W.H. Hypoxia-ischemia-induced apoptotic cell death correlates with IGF-I mRNA decrease in neonatal rat brain. Biol. Signals Recept. 8:1999;281-293.
31. Coimbra C., Drake M., Boris-Moller F., Wieloch T. Long-lasting neuroprotective effect of postischemic hypothermia and treatment with an anti-inflammatory/antipyretic drug. Evidence for chronic encephalopathic processes following ischemia. Stroke. 27:1996;1578-1585.
32. Colbourne F., Corbett D. Delayed and prolonged post-ischemic hypothermia is neuroprotective in the gerbil. Brain Res. 654:1994;265-272.
33. Colbourne F., Corbett D. Delayed postischemic hypothermia: a 6-month survival study using behavioral and histological assessments of neuroprotection. J. Neurosci. 15:1995;7250-7260.
34. Colbourne F., Li H., Buchan A.M., Clemens J.A. Continuing postischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats. Stroke. 30:1999;662-668.
35. Cserr H.F., Ostrach L.H. Bulk flow of interstitial fluid after intracranial injection of blue dextran 2000. Exp. Neurol. 45:1974;50-60.
36. Czech M.P. Signal transmission by the insulin-like growth factors. Cell. 59:1989;235-238.
37. D'Costa A.P., Prevette D.M., Houenou L.J., Wang S., Zackenfels K., Rohrer H., Zapf J., Caroni P., Oppenheim R.W. Mechanism of insulin-like growth factor regulation of programmed cell death of developing avian motor neurons. J. Neurobiol. 36:1998;379-394.
38. Delaney C.L., Cheng H.L., Feldman E.L. Insulin-like growth factor-1 prevents caspase-mediated apoptosis in Schwann cells. J. Neurobiol. 41:1999;540-548.
39. Delaney C.L., Russell J.W., Cheng H.L., Feldman E.L. Insulin-like growth factor-I and over-expression of Bcl-xL prevent glucose-mediated apoptosis in Schwann cells. J. Neuropathol. Exp. Neurol. 60:2001;147-160.
40. del Bigio M.R., Kanfer J.N., Zhang Y.W. Myelination delay in the cerebral white matter of immature rats with kaolin-induced hydrocephalus is reversible. J. Neuropathol. Exp. Neurol. 56:1997;1053-1066.
41. D'Ercole A.J., Ye P., Calikoglu A.S., Gutierrezospina G. The role of the insulin-like growth factors in the central nervous system. Mol. Neurobiol. 13:1996;227-255.
42. Dive C., Gregory C.D., Phipps D.J., Evans D.L., Milner A.E., Wyllie A.H. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim. Biophys. Acta. 1133:1992;275-285.
43. D'Mello S.R., Galli C., Ciotti T., Calissano P. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10989-10993.
44. D'Mello S.R., Borodezt K., Soltoff S.P. Insulin-like growth factor and potassium depolarization maintain neuronal survival by distinct pathways - possible involvement of PI 3-kinase in IGF-1 signaling. J. Neurosci. 17:1997;1548-1560.
45. Dziegielewska K.M., Habgood M., Jones S.E., Reader M., Saunders N.R. Protein in cerebrospinal fluid and plasma of postnatal monodelphis domestica. Comp. Biochem. Physiol. B. 92(3):1989;569-576.
46. Edwards A.D., Yue X., Squier M.V., Thoresen M., Cady E.B., Penrice J., Cooper C.E., Wyatt J.S., Reynolds E.O., Mehmet H. Specific inhibition of apoptosis after cerebral hypoxia-ischaemia by moderate post-insult hypothermia. Biochem. Biophys. Res. Commun. 217:1995;1193-1199.
47. Edwards A.D., Cox P., Hope P.L., Azzopardi D.V., Squier M.V., Mehmet H. Apoptosis in the brains of infants suffering intrauterine cerebral injury. Pediatr. Res. 42:1997;684-689.
48. Famularo G., Polchi S., Panegrossi A. Thrombolysis enters the race: a new era for acute ischaemic stroke? Eur. J. Emerg. Med. 5:1998;249-252.
49. Fawthrop D.J., Boobis A.R., Davise D.S. Mechanisms of cell death. Arch. Toxicol. 65:1991;437-444.
50. Feldman E.L., Sullivan K.A., Kim B.S., Russell J.W. Insulin-like growth factors regulate neuronal differentiation and survival. Neurobiol. Dis. 4:1997;201-214.
51. Ferguson I.A., Schweitzer J.B., Bartlett P.F., Johnson E.M. Jr. Receptor-mediated retrograde transport in CNS neurons after intraventricular administration of NGF and growth factors. J. Comp. Neurol. 313:1991;680-692.
52. Fernyhough P., Willars G.B., Lindsay R.M., Tomlinson D.R. Insulin and insulin-like growth factor I enhance regeneration in cultured adult rat sensory neurones. Brain Res. 607:1993;117-124.
53. Fossan G., Cavanagh M.E., Evans C.A.N., Malinowska D.H., Møllgard K. CSF-brain permeability in the immature sheep fetus: a CSF-brain barrier. Dev. Brain Res. 18:1985;113-124.
54. Frei E., Klusman I., Schnell L., Schwab M.E. Reactions of oligodendrocytes to spinal cord injury: cell survival and myelin repair. Exp. Neurol. 163:2000;373-380.
55. Galli C., Meucci O., Scorziello A., Werge T.M., Calissano P., Schettini G. Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis. J. Neurosci. 15:1995;1172-1179.
56. Gallyas F., Hsu M., Buzsaki G. Delayed degeneration of the optic tract and neurons in the superior colliculus after forebrain ischemia. Neurosci. Lett. 144:1992;177-179.
57. Gilmour R.S., Prosser C.G., Fleet I.R., Cocco L., Saunders J.C., Brown K.D., Corps A.N. From animal to molecule: aspects of the biology of insulin-like growth factors. Br. J. Cancer. 58:1988;23-30.
58. Ginsberg M.D., Busto R. Rodent models of cerebral ischemia. Stroke. 20:1989;1627-1642.
59. Giulian D., Vaca K., Corpuz M. Brain glia release factors with opposing actions upon neuronal survival. J. Neurosci. 13:1993;29-37.
60. Giulian D., Li J., Leara B., Keenen C. Phagocytic microglia release cytokines and cytotoxins that regulate the survival of astrocytes and neurons in culture. Neurochem. Int. 25:1994;227-233.
61. Gluckman P.D., Williams C.E. Is the cure worse than the disease? Caveats in the move from the laboratory to clinic. Dev. Med. Child Neurol. 34:1992;1015-1018.
62. Gluckman P.D., Klempt N., Guan J., Mallard C., Sirimanne E., Dragunow M., Klempt M., Singh K., Williams C., Nikolics K. A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem. Biophys. Res. Commun. 182:1992;593-599.
63. Gorelick P.B. Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls? Lancet. 355:2000;1925-1926.
64. Gorman A.M., Orrenius S., Ceccatelli S. Apoptosis in neuronal cells: role of caspases. NeuroReport. 9:1998;R49-R55.
65. Gottron F.J., Ying H.S., Choi D.W. Caspase inhibition selectively reduces the apoptotic component of oxygen-glucose deprivation-induced cortical neuronal cell death. Mol. Cell. Neurosci. 9:1997;159-169.
66. Guan J., Williams C.E., Gunning M., Mallard E.C., Gluckman P.D. The effects of IGF-1 treatment after hypoxic-ischemic brain injury in adult rats. J. Cereb. Blood Flow Metab. 13:1993;609-616.
67. Guan J., Skinner S.J., Beilharz E.J., Hua K.M., Hodgkinson S., Gluckman P.D., Williams C.E. The movement of IGF-I into the brain parenchyma after hypoxic-ischaemic injury. NeuroReport. 7:1996a;632-636.
68. Guan J., Williams C.E., Skinner S.J.M., Mallard E.C., Gluckman P.D. The effects of insulin-like growth factor (IGF)-1, IGF-2, and des-IGF-1 on neuronal loss after hypoxic-ischemic brain injury in adult rats - evidence for a role for IGF binding proteins. Endocrinology. 137:1996b;893-898.
69. Guan J., Bennet L., George S., Waldvogel H.J., Faull R.L.M., Gluckman P.D., Keunen H., Gunn A.J. Selective neuroprotective effects with insulin-like growth factor-1 (IGF-1) in phenotypic striatal neurons following ischemic brain injury in fetal sheep. Neuroscience. 95:2000a;831-839.
70. Guan J., Beilharz E.J., Skinner S.J.M., Williams C.E., Gluckman P.D. Intracerebral transportation and cellular localisation of insulin-like growth factor-1 following central administration to rats with hypoxic-ischemic brain injury. Brain Res. 853:2000b;163-173.
71. Guan J., Gunn A.J., Sirimanne E.S., Tuffin J., Gunning M., Clark R.G., Gluckman P.D. The window of opportunity for neuronal rescue with insulin-like growth factor-1 after hypoxia-ischemia in rats is critically modulated by cerebral temperature during recovery. J. Cereb. Blood Flow Metab. 20:2000c;513-519.
72. Guan J., Bennet L., Wu D., George S., Waldvogel H.J., Faull R.L.M., Gluckman P.D., Crosier P.S., Gunn A.J. Insulin-like growth factor-1 reduces white matter damage following ischemic brain injury in fetal sheep. J. Cereb. Blood Flow Metab. 2:2001a;493-502.
73. Guan J., Miller O.T., Waugh K.M., McCarthy D., Gluckman P.D. Insulin-like growth factor-1 improves somatosensory function and reduces the extent of cortical infarction and ongoing neuronal loss after hypoxia-ischemia in rats. Neuroscience. 105:2001b;299-306.
74. Gunn A.J., Gunn T.R. The 'pharmacology' of neuronal rescue with cerebral hypothermia. Early Hum. Dev. 53:1998;19-35.
75. Gunn A.J., Gunn T.R., de Haan H.H., Williams C.E., Gluckman P.D. Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J. Clin. Invest. 99:1997;248-256.
76. Hamilton M.G., Tranmer B.I., Auer R.N. Insulin reduction of cerebral infarction due to transient focal ischemia. J. Neurosurg. 82:1995;262-268.
77. Hamon G.A., Hunt T.K., Spencer E.M. In vivo effects of systemic insulin-like growth factor-I alone and complexed with insulin-like growth factor binding protein-3 on corticosteroid suppressed wounds. Growth Regul. 3:1993;53-56.
78. Hill J.M., Lesniak M.A., Pert C.B., Roth J. Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas. Neuroscience. 17:1986;1127-1138.
79. Hinks G.L., Franklin R.J. Distinctive patterns of PDGF-A, FGF-2, IGF-1 and TGF-beta 1 gene expression during remyelination of experimentally-induced spinal cord demyelination. Mol. Cell. Neurosci. 14:1999;153-168.
80. Hsu M., Sik A., Gallyas F., Horvath Z., Buzsaki G. Short-term and long-term changes in the postischemic hippocampus. Ann. N. Y. Acad. Sci. 743:1994;121-139.
81. Hu S., Peterson P.K., Chao C.C. Cytokine-mediated neuronal apoptosis. Neurochem. Int. 30:1997;427-431.
82. Iadecola C., Pelligrino D., Moskowitz M.A., Lassen N.A. Nitric oxide synthase inhibition and cerebrovasocular regulation. J. Cereb. Blood Flow Metab. 14:1994;175-192.
83. Ikeda T., Murata Y., Quilligan E.J., Choi B.H., Parer J.T., Doi S., Park S.D. Physiologic and histologic changes in near-term fetal lambs exposed to asphyxia by partial umbilical cord occlusion. Am. J. Obstet. Gynecol. 178:1998;24-32.
84. Inder T.E., Huppi P.S., Warfield S., Kikinis R., Zientara G.P., Barnes P.D., Jolesz F., Volpe J.J. Periventricular white matter injury in the premature infant is followed by reduced cerebral cortical gray matter volume at term. Ann. Neurol. 46:1999;755-760.
85. Ishimaru H., Takahashi A., Ikarashi Y., Maruyama Y. Effect of transient cerebral ischaemia on acetylcholine release in the gerbil hippocampus. NeuroReport. 5:1994;601-604.
86. Ismail I.S., Miell J.P., Scanlon M.F., Peters J.R. Effects of cholinergic modulation on serum insulin-like growth factor-1 and its binding proteins in normal and diabetic subjects. Clin. Endocrinol. 42:1995;147-152.
87. Jain, K.K., 2002. Neuroprotection: Drugs, Companies and Markets. Jain PharmaBiotech, Basel, Switzerland.
88. Jelinski S.E., Yager J.Y., Juurlink B.H. Preferential injury of oligodendroblasts by a short hypoxic-ischemic insult. Brain Res. 815:1999;150-153.
89. Jeon B.S., Jackson-lewis V., Burke R.E. 6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death. Neurodegeneration. 4(2):1995;131-137.
90. Johnston B.M., Mallard E.C., Williams C.E., Gluckman P.D. Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lambs. J. Clin. Invest. 97:1996;300-308.
91. Kaas J.H. Plasticity of sensory and motor maps in adult mammals. Annu. Rev. Neurosci. 14:1991;137-167.
92. Kane D.J., Ord T., Anton R., Bredesen D.E. Expression of bcl-2 inhibits necrotic neural cell death. J. Neurosci. Res. 40:1995;269-275.
93. Kanje M., Skottner A., Lundborg G., Sjöberg J. Does insulin-like growth factor I (IGF-1) trigger the cell body reaction in the rat sciatic nerve? Brain Res. 563:1991;285-287.
94. Kar S., Seto D., Dore S., Hanisch U.K., Quirion R. Insulin-like growth factors-I and -II differentially regulate endogenous acetylcholine release from the rat hippocampal formation. Proc. Natl. Acad. Sci. U.S.A. 94:1997;14054-14059.
95. Kawaguchi Y., Wilson C.J., Augood S.J., Emson P.C. Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci. 18:1995;527-535.
96. Kawai N., Keep R.F., Betz A.L. Hyperglycemia and the vascular effects of cerebral ischemia. Stroke. 28:1997;149-154.
97. Kazan S., Karasoy M., Baloglu H., Tuncer R. The effect of mild hypothermia, mannitol and insulin-induced hypoglycaemia on ischaemic infarct volume in the early period after permanent middle cerebral artery occlusion in the rat. Acta Neurochir. (Wien). 141:1999;979-987.
98. Klempt N.D., Klempt M., Gunn A.J., Singh K., Gluckman P.D. Expression of insulin-like growth factor binding protein-2 (IGFBP-2) following transient hypoxia-ischemia in the infant rat brain. Brain Res. 15:1992;55-61.
99. Knusel B., Hefti F. Trophic actions of IGF-I, IGF-II and insulin on cholinergic and dopaminergic brain neurons. Adv. Exp. Med. Biol. 293:1991;351-360.
100. Komoly S., Hudson L.D., Webster H.D., Bondy C.A. Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination. Proc. Natl. Acad. Sci. U.S.A. 89:1992;1894-1898.
101. 125I ]-nerve growth factor in the rat brain following a single intraventricular injection - correlation with the topographical distribution of trkA messenger RNA-expressing cells Neuroscience. 54:1993;445-460.
102. Larsen C.J. The BCL2 gene is the prototype of a gene family that controls programmed cell death (apoptosis). Ann. Genet. Paris. 37:1994;121-134.
103. LeBlanc M.H., Huang M., Patel D., Smith E.E., Devidas M. Glucose given after hypoxic ischemia does not affect brain injury in piglets. Stroke. 25:1994;1443-1447.
104. Lee W.H., Bondy C. Insulin-like growth factors and cerebral ischemia. Ann. N. Y. Acad. Sci. 679:1993;418-422.
105. Lee W.H., Clemens J.A., Bondy C.A. Insulin-like growth factors in the response to cerebral ischemia. Mol. Cell. Neurosci. 3:1992;36-43.
106. Lemon R.N. Stroke recovery. Curr. Biol. 3:1993;463-465.
107. Lesniak M.A., Hill J.M., Kiess W., Rojeski M., Pert C.B., Roth J. Receptors for insulin-like growth factors I and II: autoradiographic localization in rat brain and comparison to receptors for insulin. Endocrinology. 123:1988;2089-2099.
108. Levine S. Anoxic encephalopathy in rats. Am. J. Pathol. 36:1960;1-17.
109. Li Y., Chopp M., Jiang N., Yao F., Zaloga C. Temporal profile of in situ DNA fragmentation after transient middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 15:1995;389-397.
110. Logan A., Gonzalez A.M., Hill D.J., Berry M., Gregson N.A., Baird A. Coordinated pattern of expression and localization of insulin-like growth factor-II (IGF-II) and IGF-binding protein-2 in the adult rat brain. Endocrinology. 135:1994;2255-2264.
111. Lorek A., Takei Y., Cady E.B., Wyatt J.S., Penrice J., Edwards A.D., Peebles D., Wylezinska M., Owenreece H., Kirkbride V., Cooper C.E., Aldridge R.F., Roth S.C., Brown G., Delpy D.T., Reynolds E.O.R. Delayed ("secondary") cerebral energy failure after acute hypoxia-ischemia in the newborn piglet: continuous 48. h studies by phosphorus magnetic resonance spectroscopy Pediatr. Res. 36:1994;699-706.
112. MacGibbon G.A., Lawlor P.A., Sirimanne E.S., Walton M.R., Connor B., Young D., Williams C., Gluckman P., Faull R.L., Hughes P., Dragunow M. Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus. Brain Res. 750:1997;223-234.
113. Mandai K., Matsumoto M., Kitagawa K., Matsushita K., Mabuchi T., Colman D.R., Kamada T., Yanagihara T. Ischemic damage and subsequent proliferation of oligodendrocytes in focal cerebral ischemia. Neuroscience. 77:1997;849-861.
114. Marcoux F.W., Morawetz R.B., Crowell R.M., De Girolami U., Halsey J.H. Differential regional vulnerability in transient focal cerebral ischemia. Stroke. 13:1982;339-346.
115. Markgraf C.G., Green E.J., Watson B., McCabe P.M., Schneiderman N., Dietrich W.D., Ginsberg M.D. Recovery of sensorimotor function after distal middle cerebral artery photothrombotic occlusion in rats. Stroke. 25:1994;153-159.
116. Marshall J.F. Brain function: neural adaptations and recovery from injury. Ann. Rev. Psychol. 35:1984;277-308.
117. Mascotti F., Caceres A., Pfenninger K.H., Quiroga S. Expression and distribution of IGF-1 receptors containing a beta-subunit variant (betagc) in developing neurons. J. Neurosci. 17:1997;1447-1459.
118. Mason J.L., Ye P., Suzuki K., D'Ercole A.J., Matsushima G.K. Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J. Neurosci. 20:2000;5703-5708.
119. Matsuzaki H., Tamatani M., Mitsuda N., Namikawa K., Kiyama H., Miyake S., Tohyama M. Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons. J. Neurochem. 73:1999;2037-2046.
120. McMorris F.A., Mckinnon R.D. Regulation of oligodendrocyte development and CNS myelination by growth factors - prospects for therapy of demyelinating disease. Brain Pathol. 6:1996;313-329.
121. McMorris F.A., Mozell R.L., Carson M.J., Shinar Y., Meyer R.D., Marchetti N. Regulation of oligodendrocyte development and central nervous system myelination by insulin-like growth factors. Ann. N. Y. Acad. Sci. 692:1993;321-334.
122. Mercuri E., Guzzetta A., Haataja L., Cowan F., Rutherford M., Counsell S., Papadimitriou M., Cioni G., Dubowitz L. Neonatal neurological examination in infants with hypoxic ischaemic encephalopathy: correlation with MRI findings. Neuropediatrics. 30:1999;83-89.
123. Minamisawa H., Mellergard P., Smith M.L., Bengtsson F., Theander S., Boris-Möller F., Siesjö B.K. Preservation of brain temperature during ischemia in rats. Stroke. 21:1990a;758-764.
124. Minamisawa H., Nordstrom C.H., Smith M.L., Siesjö B.K. The influence of mild body and brain hypothermia on ischemic brain damage. J. Cereb. Blood Flow Metab. 10:1990b;365-374.
125. Minuto F., Barreca A., Del Monte P., Giordano G. Paracrine actions of IGF binding proteins. Acta Endocrinol. Copenh. 124(Suppl. 2):1991;63-69.
126. Morara S., Marcotti W., Provini L., Rosina A. Neuropeptide Y (NPY) expression is up-regulated in the rat inferior olive during development. NeuroReport. 8:1997;3743-3747.
127. Nieto-Sampedro M., Lewis E.R., Cotman C.W., Manthorpe M., Skaper S.D., Barbin G., Longo F.M., Varon S. Brain injury causes a time-dependent increase in neurotrophic activity at the lesion site. Science. 217:1982;860-861.
128. Nilsson L., Sara V.R., Nordberg A. Insulin-like growth factor 1 stimulates the release of acetylcholine from rat cortical slices. Neurosci. Lett. 88:1988;221-226.
129. Norenberg M.D. Astrocyte responses to CNS injury. J. Neuropathol. Exp. Neurol. 53:1994;213-220.
130. Ocrant I., Valentino K.L., Eng L.F., Hintz R.L., Wilson D.M., Rosenfeld R.G. Structural and immunohistochemical characterization of insulin-like growth factor I and II receptors in the murine central nervous system. Endocrinology. 123:1988;1023.
131. Ohata K., Marmarou A. Clearance of brain edema and macromolecules through the cortical extracellular space. J. Neurosurg. 77:1992;387-396.
132. Okumura A., Hayakawa F., Kato T., Kuno K., Watanabe K. MRI findings in patients with spastic cerebral palsy. I. Correlation with gestational age at birth. Dev. Med. Child Neurol. 39:1997;363-368.
133. Pahlman S., Meyerson G., Lindgren E., Schalling M., Johansson I. Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation. Proc. Natl. Acad. Sci. U.S.A. 88:1991;9994-9998.
134. Pantoni L., Garcia J.H., Gutierrez J.A. Cerebral white matter is highly vulnerable to ischemia. Stroke. 27:1996;1641-1646.
135. Pardridge, W.M., 1991. Transnasal and intraventricular delivery of drugs. In: Pardridge, W.M. (Ed.), Peptide Drug Delivery to the Brain. Raven, New York, pp. 99-122.
136. Parrizas M., Saltiel A.R., LeRoith D. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J. Biol. Chem. 272:1997;154-161.
137. Peeters-Scholte C., Koster J., Veldhuis W., van den Tweel E., Zhu C., Kops N., Blomgren K., Bar D., van Buul-Offers S., Hagberg H., Nicolay K., Van Bel F., Groenendaal F. Neuroprotection by selective nitric oxide synthase inhibition at 24 h after perinatal hypoxia-ischemia. Stroke. 33:2002;2304-2310.
138. Petito C.K., Pulsinelli W.A. Sequential development of reversible and irreversible neuronal damage following cerebral ischemia. J. Neuropathol. Exp. Neurol. 43:1984;141-153.
139. Petito C.K., Feldmann E., Pulsinelli W., Plum F. Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology. 37:1987;1281-1286.
140. Petito C.K., Olarte J.P., Roberts B., Nowak T.S., Pulsinelli W.A. Selective glial vulnerability following transient global ischemia in rat brain. J. Neuropathol. Exp. Neurol. 57:1998;231-238.
141. Petty A.M., Wettstein J.G. White matter ischaemia. Brain Res. Rev. 31:2000;58-64.
142. Ploeg V., Cintra A., Altiok N., Askelof P., Fuxe K., Fredhilm B.B. Limited distribution of pertussis toxin in rat brain after injection into the lateral cerebral ventricles. Neuroscience. 44:1991;205-214.
143. Pons S., Torres Aleman I. Basic fibroblast growth factor modulates insulin-like growth factor-1, its receptor, and its binding proteins in hypothalamic cell cultures. Endocrinology. 131:1992;2271-2278.
144. Portera-Cailliau C., Price D.L., Martin L.J. Excitotoxic neuronal death in the immature brain is an apoptosis-necrosis morphological continuum. J. Comp. Neurol. 378:1997;70-87.
145. Preston E., Sutherland G., Finsten A. Three openings of the blood-brain barrier produced by forebrain ischemia in the rat. Neurosci. Lett. 149:1993;75-78.
146. Pulsinelli W.A., Waldman S., Rawlinson D., Plum F. Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology. 32:1982;1239-1246.
147. Raff M.C. Social controls on cell survival and cell death. Nature. 356:1992;397-400.
148. Rennels M.L., Gregory T., Blaumanis O.R., Fujimoto K., Grady P.A. Evidence for a "paravascular" fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space. Brain Res. 326:1985;47-63.
149. Rennels M.L., Blaumanis O.R., Grady P.A. Rapid solute transport throughout the brain via paravascular fluid pathways. Adv. Neurol. 52:1990;431-439.
150. Resnicoff M., Abraham D., Yutanawiboonchai W., Rotman H.L., Kajstura J. The insulin-like growth factor 1 receptor protects tumor cells from apoptosis in vivo. Cancer Res. 55:1995;2463-2469.
151. Rice J.E., Vannucci R.C., Brierley J.B. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 9:1981;131-141.
152. Rodriguez-Tarduchy G., Collins M.K.L., Garcia I., Lopez-Rivas A. Insulin-like growth factor-1 inhibits apoptosis in IL-3-dependent hemopoietic cells. J. Immunol. 149:1992;535-540.
153. Roghani M., Lassarre C., Zapf J., Povoa G., Binoux M. Two insulin-like growth factor (IGF)-binding proteins are responsible for the selective affinity for IGF-II of cerebrospinal fluid binding proteins. J. Clin. Endocrinol. Metab. 73:1991;658-666.
154. Rosenthal S.M., Brunetti A., Brown E.J., Mamula P.W., Goldfine I.D. Regulation of insulin-like growth factor (IGF) I receptor expression during muscle cell differentiation. Potential autocrine role of IGF-II. J. Clin. Invest. 87:1991;1212-1219.
155. Roth S.C., Baudin J., Cady E., Johal K., Townsend J.P., Wyatt J.S., Reynolds E.O.R., Stewart A.L. Relation of deranged neonatal cerebral oxidative metabolism with neurodevelopmental outcome and head circumference at 4 years. Dev. Med. Child Neurol. 39:1997;718-725.
156. Russell J.W., Windebank A.J., Schenone A., Feldman E.L. Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal. J. Neurobiol. 36:1998;455-467.
157. Russo V.C., Werther G.A. des-(1-3)-IGF-I potently enhances differentiated cell growth in olfactory bulb organ culture. Growth Factors. 11:1994;301-311.
158. Russo V.C., Bach L.A., Fosang A.J., Baker N.L., Werther G.A. Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb. Endocrinology. 138:1997;4858-4867.
159. Samejima K., Tone S., Kottke T.J., Enari M., Sakahira H., Cooke C.A., Durrieu F., Martins L.M., Nagata S., Kaufmann S.H., Earnshaw W.C. Transition from caspase-dependent to caspase-independent mechanisms at the onset of apoptotic execution. J. Cell Biol. 143:1998;225-239.
160. Sara V.R., Hall K. Insulin-like growth factors and their binding proteins. Physiol. Rev. 70:1990;591-614.
161. Schubert P., Morino T., Miyazaki H., Ogata T., Nakamura Y., Marchini C., Ferroni S. Cascading glia reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling. Ann. N. Y. Acad. Sci. 903:2000;24-33.
162. Schwartzman R.A., Cidlowski J.A. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr. Rev. 14:1993;133-151.
163. Scott R.J., Hegyi L. Cell death in perinatal hypoxic-ischaemic brain injury. Neuropathol. Appl. Neurobiol. 23:1997;307-314.
164. Seto D., Zheng W.H., McNicoll A., Collier B., Quirion R., Kar S. Insulin-like growth factor-I inhibits endogenous acetylcholine release from the rat hippocampal formation: possible involvement of GABA in mediating the effects. Neuroscience. 115:2002;603-612.
165. Sharma H.S., Nyberg F., Westman J., Alm P., Gordh T., Lindholm D. Brain derived neurotrophic factor and insulin-like growth factor-1 attenuate upregulation of nitric oxide synthase and cell injury following trauma to the spinal cord - an immunohistochemical study in the rat. Amino Acids. 14:1998;121-129.
166. Sharp F.R., Lu A., Tang Y., Millhorn D.E. Multiple molecular penumbras after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 20:2000;1011-1032.
167. Sherrard R.M. Insulin-like growth factor 1 induces climbing fibre re-innervation of the rat cerebellum. NeuroReport. 8:1997;3325-3328.
168. Shinar Y., McMorris F.A. Developing oligodendroglia express mRNA for insulin-like growth factor-I, a regulator of oligodendrocyte development. J. Neurosci. Res. 42:1995;516-527.
169. Shuman S.L., Bresnahan J.C., Beattie M.S. Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats. J. Neurosci. Res. 50:1997;798-808.
170. Sirimanne E.S., Guan J., Williams C.E., Gluckman P.D. Two models for determining the mechanisms of damage and repair after hypoxic-ischemic injury in the developing rat brain. J. Neurosci. Methods. 55:1994;7-14.
171. Sirimanne E.S., Blumberg R.M., Bossano D., Gunning M., Edwards A.D., Gluckman P.D., Williams C.E. The effect of prolonged modification of cerebral temperature on outcome after hypoxic-ischemic brain injury in the infant rat. Pediatr. Res. 39:1996;591-597.
172. Sjöberg J., Kanje M. Insulin-like growth factor (IGF-1) as a stimulator of regeneration in the freeze-injured rat sciatic nerve. Brain Res. 485:1989;102-108.
173. Tamm I., Kikuchi T. Insulin-like growth factor-1 (IGF-1), insulin, and epidermal growth factor (EGF) are survival factors for density-inhibited, quiescent Balb/c-3T3 murine fibroblasts. J. Cell. Physiol. 143:1990;494-500.
174. Tan W.K.M., Williams C.E., During M.J., Mallard C.E., Gunning M.I., Gunn A.J., Gluckman P.D. Accumulation of cytotoxins during the development of seizures and edema after hypoxic-ischemic injury in late gestation fetal sheep. Pediatr. Res. 39:1996;791-797.
175. Tanaka K., Fukuuchi Y., Gomi S., Mihara B., Shirai T., Nogawa S., Nozaki H., Nagata E. Inhibition of nitric oxide synthesis impairs autoregulation of local cerebral blood flow in the rat. NeuroReport. 4:1993;267-270.
176. Tong Y., Dumont Y., Shen S.H., Quirion R. Comparative developmental profile of the neuropeptide Y Y1 receptor gene and protein in the rat brain. Mol. Brain Res. 48:1997;323-332.
177. Torres-Aleman I., Pons S., Arevalo M.A. The insulin-like growth factor 1 system in the rat cerebellum: developmental regulation and role in neuronal survival and differentiation. J. Neurosci. Res. 39:1994;117-126.
178. Trescher W.H., Ishiwa S., Johnston M.V. Brief post-hypoxic-ischemic hypothermia markedly delays neonatal brain injury. Brain Dev. 19:1997;326-338.
179. Vergelli M., Mazzanti B., Ballerini C., Gran B., Amaducci L., Massacesi L. Transforming growth factor-beta I inhibits the proliferation of rat astrocytes induced by serum and growth factors. J. Neurosci. Res. 40:1995;127-133.
180. Voll C.L., Auer R.N. Insulin attenuates ischemic brain damage independent of its hypoglycemic effect. J. Cereb. Blood Flow Metab. 11:1991;1006-1014.
181. Voll C.L., Whishaw I.Q., Auer R.N. Postischemic insulin reduces spatial learning deficit following transient forebrain ischemia in rats. Stroke. 20:1989;646-651.
182. Wilczak N., Keyser J.D. Insulin-like growth factor-1 receptors in normal appearing white matter and chronic plaques in multiple sclerosis. Brain Res. 772:1997;243-246.
183. Wong E.A., Ohlsen S.M., Godfredson J.A., Dean D.M., Wheaton J.E. Cloning of ovine insulin-like growth factor-I cDNAs: heterogeneity in the mRNA population. DNA. 8:1989;649-657.
184. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:1980;555-556.
185. Xu R.X., Nakamura T., Nagao S., Miyamoto O., Jin L., Toyoshima T., Itano T. Specific inhibition of apoptosis after cold-induced brain injury by moderate postinjury hypothermia. Neurosurgery. 43:1998;107-114.
186. Yamaguchi F., Itano T., Miyamoto O., Janjua N.A., Ohmoto T., Hosokawa K., Hatase O. Increase of extracellular insulin-like growth factor 1 (IGF-1) concentration following electrolytical lesion in rat hippocampus. Neurosci. Lett. 128:1991;273-276.
187. Yamaguchi T., Keino K., Fukuda J. The effect of insulin and insulin-like growth factor-I on the expression of calretinin and calbindin D-28k in rat embryonic neurons in culture. Neurochem. Int. 26:1995;255-262.
188. Ye P., D'Ercole A.J. Insulin-like growth factor 1 protects oligodendrocytes from tumor necrosis factor-alpha-induced injury. Endocrinology. 140:1999;3063-3072.
189. Ye P., Carson J., D'Ercole A.J. In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J. Neurosci. 15:1995;7344-7356.
190. Yin Q.W., Johnson J., Prevette D., Oppenheim R.W. Cell death of spinal motoneurons in the chick embryo following deafferentation: rescue effects of tissue extracts, soluble proteins, and neurotrophic agents. J. Neurosci. 14:1994;7629-7640.
191. Zhang F., Iadecola C. Reduction of focal cerebral ischemic damage by delayed treatment with nitric oxide donors. J. Cereb. Blood Flow Metab. 14:1994;574-580.
192. Zhang F.Y., White J.G., Iadecola C. Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in early stages of cerebral ischemia. J. Cereb. Blood Flow Metab. 14:1994;217-226.
193. Zheng W.H., Kar S., Quirion R. Insulin-like growth factor-1-induced phosphorylation of transcription factor FKHRL1 is mediated by phosphatidylinositol 3-kinase/Akt kinase and role of this pathway in insulin-like growth factor-1-induced survival of cultured hippocampal neurons. Mol. Pharmacol. 62:2002;225-233.
194. Zhu C.Z., Auer R.N. Intraventricular administration of insulin and IGF-1 in transient forebrain ischemia. J. Cereb. Blood Flow Metab. 14:1994;237-242.